The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Quantitative radiographic analysis of phase II and III trials in recurrent glioblastoma treated with VB-111 with or without bevacizumab or bevacizumab monotherapy.
 
Benjamin M. Ellingson
Consulting or Advisory Role - Agios; Bristol-Myers Squibb; Imaging Endpoints; Medicenna; MedQIA; Nativis; Northwest Biotherapeutics; Novogen; Omniox; Roche/Genentech; Siemens; Tocagen
Research Funding - Agios; Roche/Genentech; Siemens
Travel, Accommodations, Expenses - Nativis; Omniox; Siemens
 
Catalina Raymond
No Relationships to Disclose
 
Jingwen Yao
No Relationships to Disclose
 
Ararat Chakhoyan
No Relationships to Disclose
 
Dallas Turley
No Relationships to Disclose
 
Joseph Tsung
No Relationships to Disclose
 
Jodi Goldman
No Relationships to Disclose
 
Jacob Schlossman
No Relationships to Disclose
 
Caleb Tan
No Relationships to Disclose
 
Andrew Jacob Brenner
Honoraria - Vascular Biogenics
Consulting or Advisory Role - NanoTX; Vascular Biogenics
Research Funding - miRNA Therapeutics (Inst); Threshold Pharmaceuticals; Vascular Biogenics
Patents, Royalties, Other Intellectual Property - I have intellectual property interest in NanoTx Therapeutics
Travel, Accommodations, Expenses - Vascular Biogenics
 
Nicholas A. Butowski
Honoraria - Vascular Biogenics; Vascular Biogenics
Consulting or Advisory Role - Abbvie; Genentech/Roche; Medicenna; Omniox
Speakers' Bureau - Genentech/Roche
Research Funding - Abbvie; Bristol-Myers Squibb; Five Prime Therapeutics; Lilly; Medicenna; Merck; Merrimack; Tocagen
 
Patrick Y. Wen
Consulting or Advisory Role - AbbVie; Agios; AstraZeneca; Deciphera; Genentech/Roche; GW Pharmaceuticals; Immunomic Therapeutics; KIYATEC; Lilly; Puma Biotechnology; Taiho Pharmaceutical; Tocagen; Vascular Biogenics; VBI Vaccines; ZIOPHARM Oncology
Speakers' Bureau - Merck; Prime Oncology
Research Funding - Abbvie (Inst); Agios (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Beigene (Inst); Genentech/Roche (Inst); Kazia Therapeutics (Inst); Lilly (Inst); MediciNova (Inst); Merck (Inst); Novartis (Inst); Oncoceutics (Inst); Vascular Biogenics (Inst); Vascular Biogenics (Inst); VBI Vaccines (Inst)
 
Tamar Rachmilewitz Minei
Employment - VBL Therapeutics
Stock and Other Ownership Interests - VBL Therapeutics
 
Yael Chava Cohen
Employment - VBL Therapeutics
Leadership - VBL Therapeutics
Stock and Other Ownership Interests - VBL Therapeutics
Honoraria - Janssen; Medison; NeoPharm; Takeda
Consulting or Advisory Role - Medison; Takeda
Research Funding - Amgen
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Janssen; Medison; VBL Therapeutics
 
Dror Harats
Employment - VBL Therapeutics
Leadership - VBL Therapeutics
Stock and Other Ownership Interests - VBL Therapeutics
Patents, Royalties, Other Intellectual Property - VBL Therapeutics
Travel, Accommodations, Expenses - VBL Therapeutics
 
Timothy Francis Cloughesy
Stock and Other Ownership Interests - Notable Labs
Consulting or Advisory Role - Abbvie; Agios; Alexion Pharmaceuticals; Boehringer Ingelheim; Boston Biomedical; Bristol-Myers Squibb; Celgene; cortice; Deciphera; Genocea Biosciences; GW Pharmaceuticals; Human Longevity, Inc; Insys Therapeutics; KIYATEC; Lilly; Merck; NewGen Therapeutics; Notable Labs; Novartis; Novocure; Novogen; Oxigene; Pfizer; Puma Biotechnology; Roche/Genentech; Sunovion; Tocagen; VBI Vaccines; VBL Therapeutics; wellcome trust
Other Relationship - Global Coalition for Adaptive Research